CareDx Management

Management criteria checks 2/4

CareDx's CEO is John Hanna, appointed in Apr 2024, has a tenure of less than a year. directly owns 0.94% of the company’s shares, worth $3.80M. The average tenure of the management team and the board of directors is 2 years and 9.2 years respectively.

Key information

John Hanna

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.9%
Management average tenure2yrs
Board average tenure9.2yrs

Recent management updates

Recent updates

Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge

Apr 27
Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Mar 02
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry

Dec 27
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Dec 27
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price

Jun 29
Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price

Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)

May 16
Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)

CareDx: Shaking Off First-Mover Disadvantage

Oct 18

CareDx: Best Near Cap-Gain Health Diagnostics Prospect Say Market Makers

Aug 08

CEO

John Hanna (43 yo)

less than a year

Tenure

Mr. John Walter Hanna, Jr. is President, CEO & Director of CareDx, Inc since April 15, 2024. He served as General Manager of Endocrinology, Breast Cancer and Lymphoma at Veracyte, Inc. since January 1, 202...


Leadership Team

NamePositionTenureCompensationOwnership
Abhishek Jain
CFO & Principal Accounting Officer2yrsUS$2.34m0.041%
$ 166.2k
Peter Maag
Executive Director2.5yrsUS$299.60k0.45%
$ 1.8m
Alexander Johnson
President of Patient & Testing Services4yrsUS$5.72m0.096%
$ 387.3k
John Hanna
Presidentless than a yearno data0.94%
$ 3.8m
Marica Grskovic
Chief Operating Officer2.3yrsno datano data
Robert Woodward
Chief Scientific Officerless than a yearno datano data
GS Jha
Senior VP1.3yrsno datano data
Jeffrey Novack
General Counsel & Secretaryless than a yearno datano data
Stacey Follon
Senior VP & Head of Human Resources1.3yrsno datano data
Kashif Rathore
Chief of Patient & Digital Solutionsno datano datano data
Hal Gibson
Senior Vice President of Strategic Planning2.3yrsno datano data
Marco Scheller
Senior Vice President of Clinical Operations2.3yrsno datano data

2.0yrs

Average Tenure

46yo

Average Age

Experienced Management: CDNA's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Maag
Executive Director11.5yrsUS$299.60k0.45%
$ 1.8m
John Hanna
Presidentless than a yearno data0.94%
$ 3.8m
Fred Cohen
Independent Director21.3yrsUS$311.61k0.22%
$ 886.6k
Michael Goldberg
Independent Chairman12.5yrsUS$404.92k0.17%
$ 683.5k
Christine Cournoyer
Independent Director4.7yrsUS$316.51k0.047%
$ 189.6k
William Hagstrom
Independent Director9.2yrsUS$312.36k0.047%
$ 191.5k
Jeffrey Bluestone
Member of Advisory Boardno datano datano data
Mary Crow
Member of Advisory Boardno datano datano data
Robert Tibshirani
Member of Advisory Boardno datano datano data
George Bickerstaff
Independent Director10.1yrsUS$331.37k0.16%
$ 630.4k
Arthur Torres
Independent Director2.7yrsUS$316.83k0.012%
$ 48.4k
R. Riggsbee
Independent Directorless than a yearno datano data

9.2yrs

Average Tenure

66.5yo

Average Age

Experienced Board: CDNA's board of directors are considered experienced (9.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.